Fibromed Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Fibromed Inc.
Helix Therapeutics Inc.
Pharmaceuticals; anti-proliferative agents. Helix will pursue a three-pronged attack on fibrosis, blocking key enzymes responsible for cellular proliferation, formation of collagen and production of funtional tissue growth factor-b. The company initially plans to focus on fibrosis resulting from medical or surgical procedures.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice